LEXX
Lexaria Bioscience·NASDAQ
--
--(--)
--
--(--)
LEXX fundamentals
Lexaria Bioscience (LEXX) released its earnings on Jul 14, 2025: revenue was 174.00K (YoY 0.00%), beat estimates; EPS was -0.21 (YoY -61.54%), missed estimates.
Revenue / YoY
174.00K
0.00%
EPS / YoY
-0.21
-61.54%
Report date
Jul 14, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Lexaria Bioscience (LEXX) key financial stats and ratios, covering profitability, financial health, and leverage.
Lexaria Bioscience (LEXX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Lexaria Bioscience (LEXX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Lexaria Bioscience (LEXX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Lexaria Bioscience (LEXX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Lexaria Bioscience (LEXX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Lexaria Bioscience's management provide for the next earnings period?What factors drove the changes in Lexaria Bioscience's revenue and profit?Did Lexaria Bioscience beat or miss consensus estimates last quarter?What is Lexaria Bioscience's latest dividend and current dividend yield?What were the key takeaways from Lexaria Bioscience's earnings call?What does Lexaria Bioscience do and what are its main business segments?What were the key takeaways from Lexaria Bioscience’s earnings call?What is the revenue and EPS growth rate for Lexaria Bioscience year over year?
